COVID-19 and Behçet's disease: clinical case series

Affiliations

¹ Autoimmune Diseases, University of Barcelona, Barcelona, Catalunya, Spain gespino@clinic.cat.
² Autoimmune Diseases, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
³ Neurology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
⁴ Infectious Diseases, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
⁵ Internal Medicine, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
⁶ Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
⁷ Autoimmune Diseases, Hospital Clinic, Barcelona, Catalunya, Spain.

Comment

Gerard Espinosa et al. Ann Rheum Dis. 2021 Mar.

. 2021 Mar;80(3):e41.

doi: 10.1136/annrheumdis-2020-217778. Epub 2020 Jul 21.

¹ Autoimmune Diseases, University of Barcelona, Barcelona, Catalunya, Spain gespino@clinic.cat.
² Autoimmune Diseases, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
³ Neurology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
⁴ Infectious Diseases, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
⁵ Internal Medicine, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
⁶ Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
⁷ Autoimmune Diseases, Hospital Clinic, Barcelona, Catalunya, Spain.

No abstract available

Keywords: Behcet syndrome; epidemiology; systemic vasculitis.

Conflict of interest statement

Competing interests: None declared.

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Monti S, et al. Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.